Current Evidence on Tricuspid Regurgitation Interventions in Heart Failure
JACC: Heart Failure · 2025-08 · 13 (8) · 102493
DOI: 10.1016/j.jchf.2025.04.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Heart Failure, 2025-08. Verfasst von Rebecca T Hahn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Columbia University Medical Center, New York-Presbyterian Hospital, New York, New York, USA. Electronic address: rth2@columbi…. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Heart Failure, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 96 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Moderate or severe tricuspid regurgitation (TR) is seen in up to a quarter of patients with chronic heart failure (HF) and exceeds 50% in those with advanced HF symptoms. In patients with HF, the increasing severity of TR is associated with progressively worse survival. Data supporting the medical management of HF and TR continue to evolve with a greater appreciation of the pathophysiologic relationship between these diseases. The results of isolated tricuspid valve surgery vary based on the timing of the intervention and coexisting comorbidities. However, earlier intervention with timing optimized by the use of risk scores may improve these outcomes. Transcatheter tricuspid valve interventions have become a viable therapeutic option, particularly for high surgical risk patients, with a repair and replacement device currently commercially available, but they have yet to show mortality or HF hospitalization benefit. The timing and type of intervention as well as the expected clinical benefit of device therapy require further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Columbia University Medical Center, New York-Presbyterian Hospital, New York, New York, USA. Electronic address: rth2@columbia.edu.
- Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
- Division of Cardiology, Toronto Heart Center, St. Michael's Hospital, Toronto, Ontario, Canada.
Zitieren
APA
Hahn, R. T., Adamo, M., & Fam, N. P. (2025). Current Evidence on Tricuspid Regurgitation Interventions in Heart Failure. JACC: Heart Failure, 13(8), 102493. https://doi.org/10.1016/j.jchf.2025.04.008
Vancouver
Hahn RT, Adamo M, Fam NP. Current Evidence on Tricuspid Regurgitation Interventions in Heart Failure. JACC: Heart Failure. 2025;13(8):102493. doi:10.1016/j.jchf.2025.04.008
BibTeX
@article{Hahn2025,
author = {Hahn, Rebecca T and Adamo, Marianna and Fam, Neil P},
title = {Current Evidence on Tricuspid Regurgitation Interventions in Heart Failure},
journal = {JACC: Heart Failure},
year = {2025},
volume = {13},
number = {8},
pages = {102493},
doi = {10.1016/j.jchf.2025.04.008}
}
EUVIMED